Efficient construction of producer cell lines for a SIN lentiviral vector for SCID-X1 gene therapy by concatemeric array transfection
Open Access
- 21 May 2009
- journal article
- Published by American Society of Hematology in Blood
- Vol. 113 (21) , 5104-5110
- https://doi.org/10.1182/blood-2008-11-191049
Abstract
Retroviral vectors containing internal promoters, chromatin insulators, and self-inactivating (SIN) long terminal repeats (LTRs) may have significantKeywords
This publication has 35 references indexed in Scilit:
- Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patientsJournal of Clinical Investigation, 2008
- Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1Journal of Clinical Investigation, 2008
- An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activationBlood, 2008
- Sequential Expression of Pluripotency Markers during Direct Reprogramming of Mouse Somatic CellsCell Stem Cell, 2008
- Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cellsBlood, 2007
- Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicityBlood, 2006
- A trans-lentiviral packaging cell line for high-titer conditional self-inactivating HIV-1 vectorsMolecular Therapy, 2006
- Continuous high-titer HIV-1 vector productionNature Biotechnology, 2003
- Generation of a Stable Cell Line Producing High-Titer Self-Inactivating Lentiviral VectorsMolecular Therapy, 2001
- A Stable System for the High-Titer Production of Multiply Attenuated Lentiviral VectorsMolecular Therapy, 2000